DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)	Jun. 30, 2024 participant patient	Dec. 31, 2023 USD ($)	Jul. 31, 2023 participant
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 325,127		$ 222,798
Working capital	150,700		$ 233,600
Proceeds from term loan, net	$ 29,500
Number of patients enrolled in trail | patient		65
Number of patients enrolled in trial with one dose of study drug received | participant		62
Number of participants enrolled in trial with one dose of study drug received with primary and secondary objectives met | participant				62